Current Issue

Mar 2024View Current Issue

Introduction: MRI is one of the main tools for staging and assessing response to neoadjuvant therapy in locally advanced rectal cancer. However, there is no consensus on its role in restaging. The aim of this retrospective study was to assess the imaging response with MRI and to compare restaging MRI with histopathological findings in patients with locally advanced rectal cancer who underwent neoadjuvant therapy.

Material and Method: A significant difference was found between staging and restaging MRI in clinical stage T (Z=-5.03, p<0.0....[more]

Preoperative Radiotherapy followed by Surgery in Patients with Cervical Cancer. A Practice in Bulgaria that Needs to be Revised
Asya Konsolova, Hristina Ivanovska, Emilia Barsha, Ihsan Hasan, Stoyan Kostov, Angel Yordanov
ORIGINAL PAPER, Mar 2024
Article DOI: 10.21614/sgo-660
Read article

Introduction: Cervical cancer (CC) continues to be a significant problem in Bulgaria, with very high morbidity and mortality. The reasons for this are manifold – besides the lack of

primary prevention and screening, there are also issues related to the treatment process. This study aims to collect results and analyses data on the initial management of CC, focusing on preoperative radiotherapy and its negative impact on the survival of patients with this type of cancer in Bulgaria.

Materials and methods: This is a retrospectiv....[more]

Association between the Thyroid Hormone Levels and Metabolic Associated Fatty Liver Disease in Type 2 Diabetes Mellitus Egyptian Pat....
Abdelnaser Abdelaty Gadallah, Ahmed Abu sheneb, Ashraf Gharieb Dala, Mohamed El-Hosiny El-Sayed Esawy, Mohamed Zakarya Nooh
ORIGINAL PAPER, Mar 2024
Article DOI: 10.21614/sgo-642
Read article

Background: Metabolic associated fatty liver disease (MAFLD) can significantly increase the prevalence of chronic complications in patients with T2DM. Objectives: to analyse the association between the thyroid hormones and MAFLD in T2DM Egyptian patients.

Methods: This case control study was conducted on 180 T2DM patients with and without MAFLD who admitted to Department of Internal Medicine, and Endocrinology Unit, Faculty of Medicine, Menoufia University from December 2022 to October 2023. Patients were categorized into three groups to a....[more]

Comparative Study of TACE with Bleomycin-Lipiodol Emulsion and Percutaneous Local Bleomycin Injection in the Treatment of Giant Hepa....
Zainab Ahmed Mohammed Taha, Zaid Hadi Hammoodi, A.L. Farah Sadiq Abd Hashem
ORIGINAL PAPER, Mar 2024
Article DOI: 10.21614/sgo-634
Read article

Background: hepatic hemangiomas, primarily affecting adults in their fourth and fifth decades, are common benign mesenchymal hepatic tumors. The management of giant hepatic hemangiomas, defined variably as greater than 4 cm to 10 cm in diameter, is a clinical challenge due to their potential size and associated symptoms. This study compares two minimally invasive treatment methods: trans-catheter arterial bleomycin chemoembolization (TACE) and ultrasound and fluoroscopy-guided transhepatic bleomycin sclerotherapy (PLIB), in the treatment of giant hepatic hemangiom....[more]

Determining Risk Factors for Post-Embolization Syndrome in Patients Undergoing TACE for Hepatic Malignancies
Mazin Essa Menaf Al-Shereefi, Mustafa Khassaf, Hiba Hamid Hashim
ORIGINAL PAPER, Mar 2024
Article DOI: 10.21614/sgo-635
Read article

Background: Hepatocellular carcinoma (HCC) is a major global health concern, particularly in developing countries. Trans-catheter arterial chemoembolization (TACE) is a widely accepted nonsurgical treatment for unresectable HCC, but it is often accompanied by postembolization syndrome (PES), characterized by fever, nausea, and abdominal pain. This study aims to investigate the factors influencing the development of PES in TACE-treated patients.

Methods: This prospective cohort study included 51 patients with histologically confirmed HCC un....[more]

Search The Journal

Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Mar 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/